Primary Malignant Liver Neoplasm — Trials

Primary Malignant Liver Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

3,489 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 807
Recruiting: 471
Ph III recruiting: 42
Growth YoY: +1.5%
Industry share: 21%
Top sponsor: Sun Yat-sen University
Termination share: 34.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (403)

clinicaltrialsPublishedShowing 351–400 of 1,065 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07582419	Hybrid Deep Learning Integrating Multimodal CEUS and Enhanced MRI to Optimize Early-Stage HCC Treatment Decisions(HDL-CEUS-MRI)	not yet recruiting	—	1,424	The First Hospital of Jilin UniversityOTHER	1	May 12, 2026	clinicaltrials
NCT06794073	Efficacy and Safety of Multimodal Ablation Combined With PD-1 Monoclonal Antibody, Lenvatinib and TACE in the Treatment of Unresectable Primary Hepatocellular Carcinoma: A Single-Arm, Single-Center Clinical Study	recruiting	N/A	17	Shanghai Zhongshan Hospital